Comprehensive Report on the Orthobiologics Market: Opportunities and Challenges
This study helps professionals make sense of complex market trends and competitive shifts affecting the orthobiologics industry today.
What Is The Expected CAGR For The Orthobiologics Market Through 2025?
The orthobiologics market size has grown strongly in recent years. It will grow from $7.08 billion in 2024 to $7.48 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to the rise in prevalence of orthopedic diseases and conditions, shift towards minimally invasive procedures, rise in number of reconstructive surgeries, increase in healthcare expenditure, awareness among patients and healthcare providers, and economic development in emerging markets.
The orthobiologics market size is expected to see strong growth in the next few years. It will grow to $9.39 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to the aging population and sedentary lifestyles, ongoing development of advanced products, favorable reimbursement policies, regulatory approvals for new orthobiologic products, and expanded indications for existing orthobiologic products. Major trends in the forecast period include advancements in regenerative medicine, product innovations, technological advancements, strategic initiatives, and market expansion.
Get your free sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16139&type=smp
Which Key Factors Will Influence Orthobiologics Market Growth Over 2025–2034?
The increasing number of road accidents and sports injuries is expected to propel the growth of the orthobiologics market going forward. Road accidents and sports injuries refer to incidents causing physical harm to individuals, often involving the musculoskeletal system. Road accidents and sports injuries are fueled by factors such as distracted driving, speeding, poor road conditions for accidents, overuse, improper equipment, and lack of proper training for sports injuries. Orthobiologics help in the treatment of road accidents and sports injuries by promoting faster and more effective healing of musculoskeletal tissues, reducing inflammation, and enhancing the body’s natural repair processes through the use of substances such as bone grafts, growth factors, stem cells, and platelet-rich plasma. For instance, in March 2024, according to Eurostat, a Europe-based statistical office of the European Union, in 2022, there were 20653 people killed in Europe by road accidents, up from 3.7% compared to 19917 in 2021. Therefore, the increasing number of sports injuries and road accidents will drive the orthobiologics market..
Comprehensive Segment-Wise Insights Into The Orthobiologics Market
The orthobiologicsmarket covered in this report is segmented —
1) By Product Type: Viscosupplements; Bone Growth Factors; Demineralized Bone Matrix; Synthetic Bone Substitutes; Cellular Allograft; Other Products
2) By Application: Spinal Fusion; Maxillofacial And Dental; Soft Tissue Repair; Reconstructive And Fracture Surgery; Other Applications
3) By End User: Hospitals; Orthopedic Clinics; Ambulatory Surgery Centers; Other End Users
Subsegments:
1) By Viscosupplements: Hyaluronic Acid Injections; Gel-Based Viscosupplements; Cross-linked Hyaluronic Acid; Other Viscosupplement Products
2) By Bone Growth Factors: Bone Morphogenetic Proteins (BMPs); Recombinant Human Bone Morphogenetic Proteins (rhBMPs); Platelet-Rich Plasma (PRP); Osteogenic Protein-1 (OP-1); Growth Factors For Bone Healing
3) By Demineralized Bone Matrix: DBM Grafts; DBM Putty; DBM Sponges; DBM Paste And Chips
4) By Synthetic Bone Substitutes: Calcium Phosphate-Based Substitutes; Calcium Sulfate-Based Substitutes; Tricalcium Phosphate (TCP); Hydroxyapatite (HA); Bioactive Glasses; Other Synthetic Bone Substitutes
5) By Cellular Allograft: Osteocellular Allografts; Mesenchymal Stem Cells (MSCs) Allografts; Bone Marrow-Derived Cellular Allografts; Adipose Tissue-Derived Cellular Allografts
6) By Other Products: Autografts; Collagen-Based Grafts; Synthetic Bone Graft Substitutes (Non-Bioactive); Amniotic Membrane-Based Grafts; Exosome-Based Products; Other Miscellaneous Orthobiologic Products
What Are The Prominent Trends In The Orthobiologics Market?
Major companies operating in the orthobiologics market are developing advanced solutions, such as dry allograft mixtures, to enhance bone healing and fusion in orthopedic procedures. Dry allograft mixtures integrate robust cortical fibers with mineralized cortical bone, providing structural support and promoting osteoinductive properties that aid in new bone formation. For instance, in May 2024, Isto Biologics, a US-based biologics-focused company, launched Fibrant Liberty allograft, a dry allograft mixture that integrates robust cortical fibers with mineralized cortical cancellous chips. Upon hydration, the graft becomes pliable and can be customized for various surgical procedures. The longer and stronger fibers enhance handling and form an intricate network that prevents graft migration while maintaining structural integrity.
Analysis Of Key Players In Orthobiologics Market
Major companies operating in the orthobiologics market are Johnson & Johnson, Medtronic plc, Zimmer Biomet, Arthrex Inc., Integra Lifesciences Corporation, NuVasive Inc., Globus Medical, Bioventus, MTF Biologics, ATEC Spine Inc., Exactech Inc., SeaSpine, RTI Surgical, AlloSource, XTANT MEDICAL, Spine Wave Inc., Bone Biologics Corp., Locate Bio Limited, Wright Medical Group N.V., BoneSupport AB, Graftys, Regenexx, Acumed LLC, Baxter International Inc., LifeNet Health
View the full orthobiologics market report here:
https://www.thebusinessresearchcompany.com/report/orthobiologics-global-market-report
What Are The Key Regional Trends In The Orthobiologics Market?
North America was the largest region in the orthobiologics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the orthobiologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Americas +1 310–496–7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment